Europe PMC
open access
CC BY 4.0
Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globally
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- External Validation of the 4C Mortality Score for Hospitalised Patients With COVID-19 in a Tunisian Cohort#1048069
- The Impact of COVID-19 on Medical Education: Perspectives from Pre-Clinical and Clinical Students#281769
- Treatment and Outcomes in Patients With COVID-19 and Competing Acute Surgical Diseases in Moscow#981455
- COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19#857730
- The impact of the COVID-19 coronavirus pandemic on the surgical management of gynecological cancers: Analysis of the multicenter database of the French SCGP and the FRANCOGYN group#350763
Record · ID 445489
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive